SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,019,000 | -90.4% | 25,850 | -79.2% | 0.06% | -91.5% |
Q4 2020 | $21,141,000 | +178.8% | 124,000 | +129.6% | 0.77% | +96.7% |
Q3 2020 | $7,583,000 | -74.2% | 54,000 | -70.6% | 0.39% | -86.2% |
Q2 2020 | $29,406,000 | +67.6% | 183,400 | +2.2% | 2.83% | +35.7% |
Q1 2020 | $17,549,000 | +24.8% | 179,400 | +64.6% | 2.08% | +68.5% |
Q4 2019 | $14,065,000 | +86.7% | 109,000 | +9.0% | 1.24% | -3.9% |
Q3 2019 | $7,532,000 | +256.1% | 100,000 | +525.0% | 1.29% | +51.8% |
Q2 2018 | $2,115,000 | -6.7% | 16,000 | -68.0% | 0.85% | +27.7% |
Q3 2017 | $2,268,000 | +124.3% | 50,000 | +66.7% | 0.66% | +65.6% |
Q2 2017 | $1,011,000 | -58.8% | 30,000 | -25.0% | 0.40% | -46.2% |
Q3 2016 | $2,456,000 | +25.8% | 40,000 | -60.0% | 0.75% | -16.0% |
Q1 2016 | $1,952,000 | +838.5% | 100,000 | +1751.9% | 0.89% | +909.1% |
Q4 2015 | $208,000 | +20.2% | 5,400 | 0.0% | 0.09% | -11.1% |
Q3 2015 | $173,000 | +5.5% | 5,400 | 0.0% | 0.10% | +17.9% |
Q2 2015 | $164,000 | +127.8% | 5,400 | 0.0% | 0.08% | +127.0% |
Q1 2015 | $72,000 | – | 5,400 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |